UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients.

Prentice, HG and Potter, MN and Mattes, FM and Hainsworth, E and Murdin-Geretti, A and Nebbia, G and Burroughs, AK and Sweeny, P and Hassan-Walker, AF and Okwuadi, S and Emery, VC and Griffiths, PD (2001) A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients. BLOOD , 98 (11) 395A - 395A.

Full text not available from this repository.


Type:Article
Title:A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients.
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Infection and Immunity (Division of) > Research Department of Infection
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)

Archive Staff Only: edit this record